Total Funding
48
74
Total FundingFunding Round raised
Growth Score
-2 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49123
Perfuiso markets an FDA cleared non-invasive surgical imaging device.
Bruce Ferguson, MD: Co-Founder and Chief Medical Officer
Peter Geiger: Chief Financial OfficerPast Role: DSM, VP Finance, Business Unit Controller
About the Company
Perfusio is a medical device company that develops and markets an innovative and transformational platform technology for non-invasive, instantaneous surgical imaging of intact and diseased tissue. The company's FDA-cleared Certes system resolves this dilemma by providing real-time visualization of blood flow and tissue perfusion during
surgery. This additional knowledge enables surgeons to make better-informed and more accurate decisions at critical junctures. Seeing real-time blood flow allows surgeons to identify and fix problems, avoid potential complications, and sustainably improve patient outcomes.
Perfusio was founded in 2014 and is headquartered in Greenville, North Carolina, United States.
